作者：
Stephenson, Diane [1]
;
Aviles, Enrique [2]
;
Bain, Lisa J. [3]
;
Brumfield, Martha [4]
;
Carrillo, Maria [5]
;
Comery, Thomas A. [6]
;
Compton, Carolyn [7]
;
Corrigan, Brian [8]
;
Gordon, Mark Forrest [9]
;
Jack, Clifford R., Jr. [10]
;
Katz, Russell [11]
;
Logovinsky, Veronika [12]
;
Satlin, Andrew [13]
;
Marek, Ken [14]
;
Nicholas, Timothy [15]
;
Polhamus, Dan ;
Angersbach, B. Steven ;
Raghavan, Nandini ;
Romano, Gary ;
Romero, Klaus ;
Shaw, Leslie ;
Woodcock, Janet ;
Vradenburg, George ;
Isaac, Maria
作者单位：
Inst Neurodegenerat Disorders, New Haven, CT USA
[1]
Metrum Res Grp, Tariffville, CT USA
[2]
US FDA, Silver Spring, MD USA
[3]
US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4]
Arizona State Univ, Phoenix, AZ USA
[5]
EMA, London, England
[6]
Eisai Inc, Woodcliff Lake, NJ USA
[7]
USAgainst Alzheimers, Washington, DC USA
[8]
Mayo Clin, Rochester, MN USA
[9]
Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[10]
Crit Path Inst, Tucson, AZ 85718 USA
[11]
Alzheimers Assoc, Chicago, IL USA
[12]
Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[13]
Pfizer Inc, New London, CT USA
[14]
Johnson & Johnson, Raritan, NJ USA
[15]
发布时间
2015-10-08
换一批
